Literature DB >> 26906673

Diabetes and Kidney Disease: Role of Oxidative Stress.

Jay C Jha1, Claudine Banal1, Bryna S M Chow1, Mark E Cooper1,2, Karin Jandeleit-Dahm1,2.   

Abstract

SIGNIFICANCE: Intrarenal oxidative stress plays a critical role in the initiation and progression of diabetic kidney disease (DKD). Enhanced oxidative stress results from overproduction of reactive oxygen species (ROS) in the context of concomitant, insufficient antioxidant pathways. Renal ROS production in diabetes is predominantly mediated by various NADPH oxidases (NOXs), but a defective antioxidant system as well as mitochondrial dysfunction may also contribute. Recent Advances: Effective agents targeting the source of ROS generation hold the promise to rescue the kidney from oxidative damage and prevent subsequent progression of DKD. Critical Issues and Future Directions: In the present review, we summarize and critically analyze molecular and cellular mechanisms that have been demonstrated to be involved in NOX-induced renal injury in diabetes, with particular focus on the role of increased glomerular injury, the development of albuminuria, and tubulointerstitial fibrosis, as well as mitochondrial dysfunction. Furthermore, novel agents targeting NOX isoforms are discussed. Antioxid. Redox Signal. 25, 657-684.

Entities:  

Keywords:  NADPH-oxidases; albuminuria; diabetic nephropathy; reactive oxygen species

Mesh:

Substances:

Year:  2016        PMID: 26906673      PMCID: PMC5069735          DOI: 10.1089/ars.2016.6664

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  281 in total

Review 1.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

Review 2.  Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease.

Authors:  Maqsood M Elahi; Khalid M Naseem; Bashir M Matata
Journal:  FEBS J       Date:  2007-01-22       Impact factor: 5.542

3.  Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone.

Authors:  Yaxian Ding; Zi-Jiang Chen; Shiguo Liu; Danian Che; Michael Vetter; Chung-Ho Chang
Journal:  J Pharm Pharmacol       Date:  2005-01       Impact factor: 3.765

4.  The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.

Authors:  J Y Youn; L Gao; H Cai
Journal:  Diabetologia       Date:  2012-05-02       Impact factor: 10.122

5.  Phosphatidic acid and diacylglycerol directly activate NADPH oxidase by interacting with enzyme components.

Authors:  A Palicz; T R Foubert; A J Jesaitis; L Marodi; L C McPhail
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

6.  Cell transformation by the superoxide-generating oxidase Mox1.

Authors:  Y A Suh; R S Arnold; B Lassegue; J Shi; X Xu; D Sorescu; A B Chung; K K Griendling; J D Lambeth
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

7.  Peroxynitrite plays a key role in glomerular lesions in diabetic rats.

Authors:  Hui Xiao; Yanning Li; Jinsheng Qi; Hui Wang; Kun Liu
Journal:  J Nephrol       Date:  2009 Nov-Dec       Impact factor: 3.902

Review 8.  Diabetic nephropathy: mechanisms of renal disease progression.

Authors:  Yashpal S Kanwar; Jun Wada; Lin Sun; Ping Xie; Elisabeth I Wallner; Sheldon Chen; Sumant Chugh; Farhad R Danesh
Journal:  Exp Biol Med (Maywood)       Date:  2008-01

9.  Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production.

Authors:  Sergey I Dikalov; Anna E Dikalova; Alfiya T Bikineyeva; Harald H H W Schmidt; David G Harrison; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

10.  Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.

Authors:  Vasantha Kolavennu; Lixia Zeng; Hui Peng; Yin Wang; Farhad R Danesh
Journal:  Diabetes       Date:  2007-12-14       Impact factor: 9.461

View more
  124 in total

1.  Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.

Authors:  Jay C Jha; Aozhi Dai; Chet E Holterman; Mark E Cooper; Rhian M Touyz; Chris R Kennedy; Karin A M Jandeleit-Dahm
Journal:  Diabetologia       Date:  2019-06-20       Impact factor: 10.122

2.  Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.

Authors:  Donald E Wesson; Jerry M Buysse; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2020-01-27       Impact factor: 10.121

Review 3.  Formation and repair of oxidatively generated damage in cellular DNA.

Authors:  Jean Cadet; Kelvin J A Davies; Marisa Hg Medeiros; Paolo Di Mascio; J Richard Wagner
Journal:  Free Radic Biol Med       Date:  2017-01-02       Impact factor: 7.376

4.  Connexin32 ameliorates renal fibrosis in diabetic mice by promoting K48-linked NADPH oxidase 4 polyubiquitination and degradation.

Authors:  Zhiquan Chen; Xiaohong Sun; Qiuhong Chen; Tian Lan; Kaipeng Huang; Haiming Xiao; Zeyuan Lin; Yan Yang; Peiqing Liu; Heqing Huang
Journal:  Br J Pharmacol       Date:  2019-12-23       Impact factor: 8.739

5.  DESI-MSI and METASPACE indicates lipid abnormalities and altered mitochondrial membrane components in diabetic renal proximal tubules.

Authors:  Guanshi Zhang; Jialing Zhang; Rachel J DeHoog; Subramaniam Pennathur; Christopher R Anderton; Manjeri A Venkatachalam; Theodore Alexandrov; Livia S Eberlin; Kumar Sharma
Journal:  Metabolomics       Date:  2020-01-10       Impact factor: 4.290

6.  LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β-Induced Angiogenesis.

Authors:  Quan Hong; Lu Zhang; Jia Fu; Divya A Verghese; Kinsuk Chauhan; Girish N Nadkarni; Zhengzhe Li; Wenjun Ju; Matthias Kretzler; Guang-Yan Cai; Xiang-Mei Chen; Vivette D D'Agati; Steven G Coca; Detlef Schlondorff; John C He; Kyung Lee
Journal:  J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 10.121

Review 7.  Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy.

Authors:  Munehiro Kitada; Yoshio Ogura; Itaru Monno; Daisuke Koya
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

8.  PHLPP1/Nrf2-Mdm2 axis induces renal apoptosis via influencing nucleo-cytoplasmic shuttling of FoxO1 during diabetic nephropathy.

Authors:  Alpana Mathur; Vivek Kumar Pandey; Mohammad Fareed Khan; Poonam Kakkar
Journal:  Mol Cell Biochem       Date:  2021-05-31       Impact factor: 3.396

9.  ASK1 contributes to fibrosis and dysfunction in models of kidney disease.

Authors:  John T Liles; Britton K Corkey; Gregory T Notte; Grant R Budas; Eric B Lansdon; Ford Hinojosa-Kirschenbaum; Shawn S Badal; Michael Lee; Brian E Schultz; Sarah Wise; Swetha Pendem; Michael Graupe; Laurie Castonguay; Keith A Koch; Melanie H Wong; Giuseppe A Papalia; Dorothy M French; Theodore Sullivan; Erik G Huntzicker; Frank Y Ma; David J Nikolic-Paterson; Tareq Altuhaifi; Haichun Yang; Agnes B Fogo; David G Breckenridge
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

10.  Podocyte and endothelial-specific elimination of BAMBI identifies differential transforming growth factor-β pathways contributing to diabetic glomerulopathy.

Authors:  Han Lai; Anqun Chen; Hong Cai; Jia Fu; Fadi Salem; Yu Li; John C He; Detlef Schlondorff; Kyung Lee
Journal:  Kidney Int       Date:  2020-04-26       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.